Skip to main content
. 2015 Jul 14;17(1):58. doi: 10.1186/s12968-015-0168-3

Table 4.

Patient Characteristics, Gadolinium Dose, and Characteristics of Reaction

All Gadopentetat (Magnevist) Gadoteracid (Dotarem) Gadobenat (Multihance) Gadotbutrol (Gadovist) Gadoteridol (Prohance) Gadodiamide (Omniscan) Other*
All 45 20 5 3 9 2 3 3
Age (years, mean) 51.9 50.8 48.2 68.0 49.6 38.0 62.0 56.0
SD 16.5 18.1 19.0 4.6 16.1 14.1 4.0 13.0
Median 54.0 54.0 53.0 69.0 42.0 38.0 62.0 56.0
Range 16-77 16-74 25-69 63-72 31-77 28-48 58-66 43-69
Sex
Male (%) 62.2 75.0 60.0 33.3 44.4 50 66.7 66.7
Contrast dose (ml, mean) 20.6 22.5 24.8 13.7 13.2 14.3 20.0 23.0
SD 8.3 7.5 8.8 3.2 4.3 17.0 8.0 11.5
Median 20.0 22.5 28.0 15.0 14.0 28.0 20.0 27.0
Range 7-40 7-36 10-32 10-16 10-21 16-40 12-28 10-32
Category of reaction
Mild 43 18 5 3 9 2 3 3
Moderate 0 0 0 0 0 0 0 0
Severe 2 2 0 0 0 0 0 0
Symptoms
Allergic shock 2 2 0 0 0 0 0 0
Cardiac arrest 0 0 0 0 0 0 0 0
Dyspnoea 1 1 0 0 0 0 0 0
Bronchospasm 1 1 0 0 0 0 0 0
Nausea 10 3 0 1 2 0 2 2
Vomiting 6 3 0 0 0 0 2 1
Warmth 3 2 0 1 0 0 0 0
Headache 2 1 0 0 0 0 0 1
Dizziness 5 3 0 0 0 0 2 0
Altered taste 1 0 0 0 0 0 0 1
Itching 9 2 1 1 4 1 0 0
Flushing 10 2 1 1 6 0 0 0
Chills 2 1 0 0 1 0 0 0
Sweats 3 2 0 0 1 0 0 0
Rash/Hives 15 4 4 2 2 2 1 0
Swelling of eye/face 1 1 0 0 0 0 0 0
Anxiety 6 6 0 0 0 0 0 0
Treatment
Observation 30 14 3 2 5 1 2 3
Antihistamines 18 4 3 2 4 1 3 1
Steroids 14 3 1 2 3 2 3 0
Adrenaline 2 2 0 0 0 0 0 0

*Dotarem is included in Other